Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|March 25, 2024
Dual targeting of TIGIT and PD-1 with a novel small molecule for cancer immunotherapyYang Li, Beibei Li, Qingchao Wang, et al.
Microbiome|June 4, 2026
Multi-omics characterization of the skin microbiota reveals the anti-aging roles of Stenotrophomonas maltophiliaDanni Guo, Yuanyuan Chen, Yahong Wu, et al.
Theranostics|June 23, 2021
Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axisShanshan Gou, Shuai Wang, Wenwen Liu, et al.
European Journal of Epidemiology|January 28, 2023
Circulating lipoprotein (a) and all-cause and cause-specific mortality: a systematic review and dose-response meta-analysisMojgan Amiri, Hamidreza Raeisi-Dehkordi, Auke J C F Verkaar, et al.
Annals of Clinical and Translational Neurology|April 25, 2025
CNS Mitochondria-Derived Vesicle in Blood: Potential Biomarkers for Brain Mitochondria DysfunctionQi Liu, Wentao Chen, Yahong Wu, et al.
Cell Death & Disease|February 27, 2022
Identification of Nanog as a novel inhibitor of Rad51Ying Xin, Juanjuan Wang, Yahong Wu, et al.
BMC Biology|January 28, 2025
Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapyXiangrui Zhang, Lihan Zhang, Beibei Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2026
Development of a lymph node-homing peptide vaccine targeting C-C chemokine receptor 7-positive dendritic cells with enhanced antitumor immunityLiwei Pang, Mingshuang Wang, Jiani Fan, et al.
Biomolecules|June 2, 2021
Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-TherapyXiuman Zhou, Ling Jiao, Yuzhen Qian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2021
An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapyWanqiong Li, Xueqin Zhu, Xiuman Zhou, et al.
Pageof 8